Synergistic treatment of multiple sclerosis and other neurodegenerative disorders

摘要: Synergistic treatment of multiple sclerosis and other neurodegenerative disorders comprises co-administration an interferon- beta derivative, a prostacyclin, carbacyclin or isocarbacyclin derivative phosphodiesterase IV inhibitor. A composition (1) compound, (2) (or where applicable, its salts, cyclodextrin clathrates liposome-encapsulated forms) prostacyclin mimetic, (3) inhibitor racemates enantiomers.